Jord BioScience Raises Series B Funding to Accelerate Agricultural Microbial Solutions

Summary
Full Article
Jord BioScience, a science and analytics company specializing in agricultural microbial solutions, has successfully closed a Series B funding round aimed at scaling its innovative technology for crop input development. The investment, led by Silver Blue LLC, will enable the company to accelerate its mission of transforming agricultural productivity through advanced microbial technologies.
The funding round, which included participation from Discovery Capital Funding, Minnesota's Small Business Credit Initiative, and existing investors, validates the company's approach to developing biological solutions for major crops like corn, soybeans, canola, and wheat. With a proprietary microbial bank containing more than 6,500 unique isolates collected from diverse global soils, Jord BioScience is positioned to significantly impact agricultural innovation.
The investment is particularly significant given the increasing pressures on agricultural systems to improve productivity while maintaining environmental sustainability. By offering a fast and cost-effective approach to product development, Jord BioScience can help agricultural companies reduce the time required to bring new biological solutions to market from years to less than 10 months.
Dr. Keri Carstens, president and CEO, emphasized the strategic importance of this funding, noting that it will enable the company to scale operations and support biologicals and crop input companies in accelerating product discovery and innovation for farmers worldwide. The company's technology, built on over 30 years of microbial science research, offers a unique capability to enhance, protect, and promote crop performance through targeted microbial solutions.
Francis Goelet from Silver Blue LLC highlighted the potential of Jord BioScience to address critical challenges in agricultural productivity, particularly as farmers face increasing financial and environmental pressures. The investment signals confidence in the company's approach to bringing more consistent and effective biological solutions to the agricultural market.

This story is based on an article that was registered on the blockchain. The original source content used for this article is located at News Direct
Article Control ID: 39122